Company · CIK 0001745999 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Beam Therapeutics Inc. · BEAM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 GForm 4 → | Sep 25, 4:05 pm EDT | Giuseppe CiaramellaPresident | 123,407 | — | — | 130,504 | — | |
| Jul 27, 2026 SForm 4 → | Jul 29, 4:05 pm EDT | Amy SimonChief Medical Officer | 16,667 | $25.74 | $429,037 | 85,696 | −16.3% | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:05 pm EDT | Amy SimonChief Medical Officer | 373 | $34.73 | $12,954 | 102,363 | −0.36% | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jul 1, 4:05 pm EDT | John M. EvansCEO, Director | 50,000 | $34.90 | $1,745,037 | 1,047,205 | −4.56% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jul 1, 4:05 pm EDT | John M. EvansCEO, Director | 50,000 | $0.8956 | $44,781 | 1,072,205 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 MForm 4 → | Jul 1, 4:05 pm EDT | John M. EvansCEO, Director | 50,000 | — | — | 205,804 | — | 10b5-1 |